Avaamo says its software now handles billions of enterprise conversations a year across 40-plus countries, yet the Indian company that carries its name booked just ₹31.8 crore (about $3.3 million) in revenue in the year to March 2024. That gap is the whole story. Avaamo is an Indian-founded, Silicon Valley-headquartered conversational AI firm, and the modest number filed with India’s Registrar of Companies is not the group’s real scale — it is the accounting shadow of a research-and-support arm sitting inside a US business whose revenue never lands in Bengaluru.
The company was started in April 2014 by two men who had spent 15 years at TIBCO watching machines learn to talk to each other. Their bet was that the next frontier was getting humans to talk to those machines just as naturally. A decade on, that bet has survived the arrival of ChatGPT, a competitive field flush with far more capital, and a wholesale rewrite of what “conversational AI” even means. This is how Avaamo was built, how it earns, and where it is fragile.
Quick facts
| Company | Avaamo Inc. (US parent, Los Altos, California); Avaamo Technologies Private Limited (India arm, Bengaluru) |
| Founded | April 2014 (US); India entity incorporated 25 June 2014 |
| Founder(s) | Ram Menon (co-founder and CEO); Sriram Chakravarthy (co-founder and CTO) |
| Businesses | Enterprise conversational and agentic AI — voice and chat AI agents for healthcare, employee/IT support and customer service |
| Latest FY revenue (India arm) | ₹31.8 crore in FY24 (year to March 2024), per MCA filings via Tracxn and Tofler |
| Latest FY profit/loss | Not separately disclosed in free filings; the India entity is a services captive, not the group’s profit centre |
| Listed | Private |
| Market value / last valuation | Reported at roughly $36 million–$62 million in September 2019 (PitchBook, single tracker); no verified recent valuation |
| Key shareholders / CEO | Ram Menon (CEO); backers include Intel Capital, Wipro Ventures, Ericsson Ventures, Mahindra Partners, WI Harper, BluePointe Ventures |
What Avaamo does
Avaamo builds AI agents that hold real, multi-turn conversations for large organisations — over the phone, in chat, and inside workplace tools — and increasingly complete the task rather than just answer the question. It sells to enterprises, not consumers. The core buyers sit in three functions:
- Healthcare: patient scheduling, triage and support agents that integrate with electronic health record systems such as Epic (deployments named include Sentara Health, Deaconess Health System, UC Health and Mass General).
- Employee and IT support: “Workplace Agents” that automate HR queries, IT service-desk tickets and procurement requests while enforcing company policy (launched 2025).
- Customer service and contact centres: voice and chat automation across banking, insurance, telecom and retail, marketed as an AI contact-centre platform.
Company-stated scale, from Avaamo’s own site (as of 2026): more than 5.3 billion agent interactions handled, about 7,000 agents deployed, and 500 million monthly active users. In its December 2024 materials the company described “over 2 billion interactions annually in 114 languages.” These are company figures, not audited, and should be read as such.
The origin
Ram Menon spent 15 years at TIBCO, helping turn a Palo Alto software company into a global one before it was taken private in a $4.3 billion deal in 2014. TIBCO’s whole business was middleware — the plumbing that lets one enterprise system talk to another. Menon’s founding question inverted it. “TIBCO pioneered how systems talk to systems,” he has said. “Given where tech is today, we wondered: how do human beings best talk to systems?”
He and Sriram Chakravarthy, a longtime TIBCO colleague who had built high-performance messaging systems there, co-founded Avaamo in April 2014. The team was deliberately senior; Menon has described assembling people with more than 150 years of combined enterprise-software experience. From the start the design philosophy was unusual for the era: Menon argued that in enterprise settings “precision and accuracy matter more than personality.” The goal was not a charming assistant but a reliable one, able to ask follow-up questions, understand context, and get a banking or healthcare task right in the customer’s own language.
India was in the founding DNA. Menon was born and raised in India and trained as an industrial engineer; the India entity, Avaamo Technologies Private Limited, was registered in Bengaluru’s Koramangala in June 2014, weeks after the US company began. Bengaluru became the engineering and research base — a pattern common to Indian-origin, US-headquartered software firms, where the intellectual property and customer contracts sit in the US and the build happens in India.
The struggle years
Avaamo’s hard years were not a single near-death; they were a slow squeeze that first-generation conversational AI companies all felt. Two pressures stand out, both documented.
The first was capital. Avaamo raised a $6.3 million seed in October 2014 and a $14.2 million Series A in May 2018 — roughly $20 million of equity in its first seven years. That is modest for enterprise software. When its next disclosed financing came, in August 2021, it was a $7 million debt round from LIQUiDITY Group rather than a large equity up-round. Debt at that stage, in a market where rivals were raising nine-figure equity cheques, is a signal that a priced round on attractive terms was hard to get. Avaamo had to grow carefully while better-funded competitors spent freely on go-to-market.
The second pressure was existential and technical. Avaamo’s early platform was built on intent-based models — you defined the questions users might ask and mapped them to answers and actions. Then, in November 2022, ChatGPT arrived and made large language models look like they could generate any answer for free. For a company whose value was building and tuning intent-based bots, the risk was commoditisation: why pay Avaamo to model conversations a foundation model seemed to handle out of the box? The founders were blunt that raw LLMs are dangerous in their core markets — hallucinations that would be merely annoying in a consumer app can be “catastrophic in healthcare and finance,” as the company frames it. Avaamo had to rebuild around generative AI without inheriting its failure modes, or be left selling last-generation technology.
The turning point
The turning point was Avaamo’s response to that LLM threat: rather than resist generative AI, it re-architected the product around it while adding the guardrails enterprises need. The company moved “beyond chatbots” to what CTO Sriram Chakravarthy calls agentic automation — “where AI actively completes tasks instead of merely assisting users.”
Concretely, on either side of the shift:
- Before: intent-based conversational assistants that answered queries and handed off to humans, sold as a “conversational AI platform.”
- After (2023–2025): autonomous agents built on an enterprise-tuned model the company markets for regulated industries, designed to eliminate hallucinations, enforce role-based access, and act inside enterprise workflows such as SAP, Oracle and Epic. New product lines followed — a Healthcare Workforce offering in March 2025 and Workplace Agents for employee support later that year.
The numbers the company attaches to the healthcare push give the clearest before-and-after: Avaamo says its healthcare agents have processed more than 150 million scheduling appointments and delivered over 500,000 hours in cycle-time savings, with customers reporting up to 50% reductions in operational cost. A February 2025 partnership with Sentara Health, a Virginia not-for-profit health network, marked the transition from selling bots to embedding agents in front-line patient operations. These are company-stated outcomes, but the direction is corroborated by named deployments at UC Health and Mass General using Epic integration.
The money behind it
Avaamo’s funding is best understood as small and disciplined rather than blockbuster. The disclosed rounds:
- Seed — October 2014, $6.3 million: led with BluePointe Ventures and others.
- Series A — May 2018, $14.2 million: led by Intel Capital, with Ericsson Ventures, Mahindra Partners, Wipro Ventures and WI Harper participating. Intel Capital’s Arun Chetty joined the board.
- Debt financing — August 2021, $7 million: from LIQUiDITY Group.
What each backer changed is instructive: Intel Capital gave enterprise credibility and a board seat at the moment Avaamo went upmarket; Ericsson and Wipro Ventures were strategic, opening telecom and IT-services channels; Mahindra Partners added an India-linked corporate backer. Total disclosed funding is reported between about $23.5 million (Avaamo’s own 2018 statement of cumulative funding) and $27.5 million–$31.8 million across trackers such as Inc42 and Crunchbase, the spread reflecting how the 2021 debt line is counted.
One later item should be treated with caution. A single funding-news aggregator reported a $30 million round dated 23 December 2024, with no named investors and no round type. It is not corroborated by Inc42, Tracxn or Crunchbase, which still show the earlier totals, so it is noted here as an unverified single-source claim rather than a confirmed raise. On valuation, the only figure on record is a September 2019 range of roughly $36 million–$62 million from one tracker; there is no reliable recent valuation, which is normal for a private company that has not raised a large priced round.
How it makes money
Avaamo sells enterprise software, and the money mechanics follow that model:
- Money in: subscription and usage-based contracts for its agent platform, typically annual enterprise licences scaled to interaction volume, seats or deployed agents, plus implementation and integration services.
- Where the value sits: deep integration. The platform connects to 150-plus enterprise systems — ERP, CRM, ITSM, billing, and health-record systems like Epic. Once an agent is wired into a hospital’s scheduling or a bank’s core systems, switching cost is high and contracts renew.
- Costs out: engineering and research (largely in Bengaluru), model and cloud-inference costs, security and compliance certification (HIPAA, PCI, GDPR, FINRA are all supported), and a US enterprise sales motion that is expensive per deal.
- The part people get wrong: the India-filed revenue is not the group’s sales. Avaamo Technologies Private Limited is classified in MCA records as an IT-enabled services company; its receipts are largely intra-group payments from the US parent for research and support work, booked at a services margin. The customer revenue — the enterprise licences — is recognised in the US company, which does not file public accounts. So the ₹31.8 crore is a cost-plus support number, not a demand signal.
The numbers
The only audited, government-filed financials available are for the India arm, Avaamo Technologies Private Limited, sourced from MCA filings via Tracxn and Tofler. They show steady, roughly 20% annual growth — consistent with a captive services unit scaling headcount rather than a product line chasing hypergrowth.
| Financial year (to 31 March) | Revenue (₹ crore) | Growth |
| FY22 | 22.0 | — |
| FY23 | 26.4 | +20.0% YoY |
| FY24 | 31.8 | ~+20.5% YoY |
Notes on these figures:
- Unit is ₹ crore; figures are operating revenue of the India entity only, not consolidated group revenue.
- Exact profit or loss is behind paid data walls; Tofler indicates positive net-worth growth (about 27% in FY23) and small single-digit EBITDA growth, consistent with a low-margin services captive rather than a loss-making product startup.
- Headcount at the India entity was about 121 as of 28 February 2025 (Tracxn), the bulk of the group’s engineering base.
Where the money comes from
Two splits matter — geography and vertical — and the surprise is in the first.
- Geography — sold in the US, built in India: customer contracts and IP sit with the US parent; roughly 121 of the group’s people and the core R&D sit in Bengaluru. Chakravarthy has said many enterprise clients now run their own AI centres in India and that he personally spends “half my time here.” The surprise: an “American” AI vendor’s product is largely engineered in Koramangala, yet almost none of its sales revenue is visible in Indian filings.
- Vertical — healthcare has become the anchor: Avaamo started horizontal (banking, telecom, insurance, retail) but the deepest recent traction and the loudest metrics are in healthcare — 150 million-plus appointments scheduled, marquee logos like Sentara, UC Health and Mass General, and dedicated Healthcare Workforce and Epic-integration products.
- Function — a second pillar in the workplace: the 2025 Workplace Agents line pushes into HR, IT service desk and procurement automation, diversifying away from external customer service toward internal employee support.
The concentration cuts both ways: healthcare gives Avaamo defensible, high-switching-cost deals, but it also means the company’s fortunes ride on a single, heavily regulated buyer group.
The risks
- Capital disadvantage against better-funded rivals: Avaamo has raised roughly $20 million of equity plus a $7 million debt line, while enterprise conversational and agentic AI peers such as Kore.ai, Yellow.ai and Netomi have raised far larger sums and can outspend it on sales and marketing. In enterprise software, distribution often beats product, and Avaamo is structurally under-capitalised for that fight.
- Platform commoditisation from the model layer: the biggest threat is that foundation-model providers and platform incumbents — OpenAI, Google, Microsoft, plus Salesforce and ServiceNow with native agent frameworks — fold “enterprise agents” into products customers already own. Avaamo’s defence is regulated-industry guardrails and deep integration, but the ground under standalone agent vendors is moving fast.
- Accuracy and regulatory exposure in its core markets: Avaamo’s own framing is that hallucinations are “catastrophic” in healthcare and finance. A single high-profile failure — a wrong medication instruction, a mis-scheduled critical appointment — carries legal, reputational and compliance risk far larger than the contract value, and it operates under HIPAA, PCI and FINRA regimes where the penalty for error is severe.
- Concentration and integration dependency: leaning on healthcare and on integrations with systems like Epic, SAP and Oracle means Avaamo’s roadmap is partly hostage to those platforms’ pricing, API changes and partnership decisions, and a downturn in one vertical hits disproportionately.
The takeaway
Avaamo’s transferable lesson is about surviving a platform shift you did not choose. When ChatGPT threatened to make its entire product category look obsolete overnight, Avaamo did not double down on the old approach or pretend the new one was safe. It absorbed the disruptive technology and sold the thing the disruptor could not: accuracy, integration and compliance for buyers who cannot afford a wrong answer. For a modestly funded company, that is the only durable moat — not being the biggest model, but being the most trustworthy way to put a model to work where mistakes are expensive. The ₹31.8 crore in the Indian filings will keep understating the business, because the real product was never sold from Bengaluru; it was only ever built there.
Frequently asked questions
Is Avaamo an Indian company?
It is Indian-founded but US-headquartered. The parent, Avaamo Inc., is based in Los Altos, California, and was co-founded in April 2014 by Ram Menon and Sriram Chakravarthy. Its India arm, Avaamo Technologies Private Limited, was incorporated in Bengaluru in June 2014 and houses the core engineering and research team.
What does Avaamo actually sell?
Enterprise conversational and agentic AI — voice and chat AI agents that automate tasks in healthcare (patient scheduling and support), employee and IT support, and customer service. It integrates with more than 150 enterprise systems and supports HIPAA, PCI, GDPR and FINRA compliance.
How much money has Avaamo raised?
Disclosed rounds are a $6.3 million seed (October 2014), a $14.2 million Series A led by Intel Capital (May 2018), and a $7 million debt round (August 2021). Total disclosed funding is reported between about $23.5 million and $31.8 million across trackers. A reported $30 million round in December 2024 is single-source and unverified.
What is Avaamo’s revenue?
Its India entity reported ₹31.8 crore in revenue for FY24 (year to March 2024), up about 20% from ₹26.4 crore in FY23, per MCA filings. This is a services-captive figure, not the group’s global sales; the US parent’s customer revenue is not publicly filed.
Who are Avaamo’s competitors?
Other enterprise conversational and agentic AI vendors such as Kore.ai, Yellow.ai, Netomi and Hyro, plus foundation-model and platform providers — OpenAI, Google and Microsoft, and agent frameworks from Salesforce and ServiceNow — that increasingly offer enterprise agents natively.
Sources
Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).
- PR Newswire / Avaamo — “Avaamo Raises $14.2M in Series A Funding Led By Intel Capital” (May 2018)
- Intel Capital — “Founder Q&A: Avaamo Co-Founder Ram Menon” (2019)
- Avaamo — About Us and Series A pages, avaamo.ai (2026)
- Inc42 — Avaamo funding profile (2026)
- Signalbase — “Avaamo Secures $30 Million in Funding” (December 2024, single-source, unverified)
- Tracxn — Avaamo and Avaamo Technologies Private Limited company/financials profiles (2025–2026)
- Tofler — Avaamo Technologies Private Limited financials, CIN U74999KA2014PTC081370 (2026)
- PitchBook — Avaamo company profile, valuation range (2019/2026)
- Dataquest India — “Beyond Chatbots: how Avaamo is Transforming Enterprise AI with Autonomous Agents” (interview, Sriram Chakravarthy)
- AiThority — Interview with Ram Menon, Founder and CEO, Avaamo
- Avaamo — Sentara Health partnership and Workplace Agents announcements (2025)
- Trading Economics — USD/INR reference rate (18 September 2026)
Found an error? Write to us and we’ll correct it in the open, dated, on the piece.